Center for Biomarker Research and Precision Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Department of Psychiatry, VU University Medical Center/GGZ inGeest, Amsterdam, The Netherlands.
Genome Biol. 2017 Jan 30;18(1):24. doi: 10.1186/s13059-017-1148-8.
Based on an extensive simulation study, McGregor and colleagues recently recommended the use of surrogate variable analysis (SVA) to control for the confounding effects of cell-type heterogeneity in DNA methylation association studies in scenarios where no cell-type proportions are available. As their recommendation was mainly based on simulated data, we sought to replicate findings in two large-scale empirical studies. In our empirical data, SVA did not fully correct for cell-type effects, its performance was somewhat unstable, and it carried a risk of missing true signals caused by removing variation that might be linked to actual disease processes. By contrast, a reference-based correction method performed well and did not show these limitations. A disadvantage of this approach is that if reference methylomes are not (publicly) available, they will need to be generated once for a small set of samples. However, given the notable risk we observed for cell-type confounding, we argue that, to avoid introducing false-positive findings into the literature, it could be well worth making this investment.Please see related Correspondence article: https://genomebiology.biomedcentral.com/articles/10/1186/s13059-017-1149-7 and related Research article: https://genomebiology.biomedcentral.com/articles/10.1186/s13059-016-0935-y.
基于广泛的模拟研究,麦格雷戈(McGregor)及其同事最近建议在没有细胞类型比例的情况下,使用替代变量分析(SVA)来控制 DNA 甲基化关联研究中细胞类型异质性的混杂影响。由于他们的建议主要基于模拟数据,我们试图在两项大规模实证研究中复制这些发现。在我们的实证数据中,SVA 并未完全纠正细胞类型效应,其性能有些不稳定,并且存在因去除与实际疾病过程相关的变异而可能遗漏真实信号的风险。相比之下,基于参考的校正方法表现良好,没有显示出这些局限性。这种方法的一个缺点是,如果参考甲基组学不可用(公开),则需要为一小部分样本生成一次。但是,鉴于我们观察到的细胞类型混杂的明显风险,我们认为,为了避免将假阳性发现引入文献中,值得进行这项投资。请参阅相关的对应文章:https://genomebiology.biomedcentral.com/articles/10/1186/s13059-017-1149-7 和相关的研究文章:https://genomebiology.biomedcentral.com/articles/10.1186/s13059-016-0935-y。